info@haemalogix.com
Menu
▾
Home
About Us
▾
▾
Company Overview
Mission & Vision
Team
▾
▾
Board of Directors
Management Team
Scientific Advisory Board
Corporate Governance
Patients
▾
▾
About Multiple Myeloma
Patient Resources
Our Science
▾
▾
The Need
Technology
▾
▾
Our Technology
Monoclonal Antibodies
CAR-T Cell Therapies
Bispecific Antibodies
Clinical Pipeline
Partnerships
Publications
News
▾
▾
Latest News
Videos
▾
▾
Educational Videos
KOL & Patient Interviews
Contact Us
Drug Discovery World: Redefining targeted immunotherapy in multiple myeloma through antigen innovation
Posted On:
14 May 2026
Read the full article
here.